Business Context and Reporting Period
This Form 8-K was filed by Aflac Incorporated on August 22, 2019, under Item 7.01 (Regulation FD Disclosure). The filing addresses a voluntary review initiated by Aflac Life Insurance Japan Ltd. (Aflac Japan) regarding sales practices in the Japan Post Group channel, specifically concerning the lapse and reissue of cancer policies.
Key Financial Metrics and Operational Data
- Policy Volume: Approximately 104,000 lapsed and reissued policies were identified in the Japan Post Co. Ltd. (JPC) channel between May 2018 and May 2019. An additional 2,600 such policies were sold by Japan Post Insurance Co. Ltd. (JPI) during the same period.
- Sales Trends: Daily proposal and new annualized premium volumes in August 2019 were running at approximately 25% of normal daily volumes.
- Projected Sales Decline: Assuming current trends continue, sales in the Japan Post Group channel are anticipated to decline by as much as 50% compared to 2018.
- Revenue Impact: Total third sector and first sector protection sales are projected to be down in the mid-teens for the year.
- Premium Growth Guidance: Protection-type first and third sector earned premium growth remains unchanged at 1% to 2% for the year.
Material Changes and Operational Updates
Aflac Japan commenced a rigorous review of postal channel sales in late July 2019 to determine if policyholders were disadvantaged when exchanging old cancer policies for new ones with enhanced benefits. The company clarified that lapse and reissue activity is a compliant practice designed to allow customers to maintain coverage during waiting periods for new policies. Additionally, Aflac Japan introduced a "conditional surrender" program to streamline transitions, though full implementation by JPC and JPI was delayed until late 2019 due to administrative readiness.
Outlook, Risks, and Management Commentary
Management expects sales to normalize in the future but acknowledges a clear negative impact while the investigation proceeds. The company stated it is unaware of any disruption to long-term alliance plans or capital commitments by Japan Post Holdings Co. Ltd. (JPH). Key risks identified include decreases in cancer insurance sales in Japan, foreign currency fluctuations, interest rate risk, and regulatory changes. The filing includes standard forward-looking statement disclaimers regarding uncertainties in global capital markets, investment valuations, and litigation outcomes.
Investor Verification Checklist
- Verify the extent of the voluntary review by Aflac Japan and any potential regulatory findings regarding the 106,600 lapsed and reissued policies.
- Monitor the actual sales volume in the Japan Post Group channel to see if the projected 50% decline materializes or if sales normalize sooner than anticipated.
- Confirm the timeline for the full implementation of the "conditional surrender" program by JPC and JPI.
- Assess the impact of the mid-teens decline in protection sales on the company's overall annual earnings guidance.
- Review any updates regarding the stability of the strategic alliance and capital commitment from Japan Post Holdings Co. Ltd.